# Neumora Therapeutics, Inc.: Form 8-K, filed Nov 1, 2023

- Company: [Neumora Therapeutics, Inc.](/companies/nmra.md) (CIK 1885522)
- Form: 8-K
- Filed: 2023-11-01
- Accepted by EDGAR: Nov 1, 2023, 16:01 ET
- Period: 2023-11-01
- Accession: 0001193125-23-268165
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1885522/000119312523268165/d518702d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1885522/000119312523268165/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1885522/000119312523268165/d518702d8k.htm

Filed Nov 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-268165. Last ingested by Listed: Oct 30, 2026, 16:11 ET. No prices; not investment advice.
